EXACT Sciences Corp (NASDAQ:EXAS)

CAPS Rating: 2 out of 5

An applied genomics company that develops proprietary DNA-based technologies for use in the detection of cancer.

Recs

1
Player Avatar JavaChipFool (62.55) Submitted: 12/21/2009 7:07:09 PM : Outperform Start Price: $2.97 EXAS Score: +226.63

colon cancer, ugly, avoidable

Report this Post Reply

Featured Broker Partners


Advertisement